Kingworld Medicines Group Limited (1110.HK)
HKD 0.45
(1.12%)
HKD 0.45
(1.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 280.66 Million CNY | 1.09% |
| 2022 | 277.62 Million CNY | 5.32% |
| 2021 | 263.59 Million CNY | -5.91% |
| 2020 | 280.15 Million CNY | 4.77% |
| 2019 | 267.4 Million CNY | -14.16% |
| 2018 | 311.49 Million CNY | -3.61% |
| 2017 | 323.17 Million CNY | -0.12% |
| 2016 | 323.57 Million CNY | 42.68% |
| 2015 | 226.77 Million CNY | 45.08% |
| 2014 | 156.31 Million CNY | 19.16% |
| 2013 | 131.17 Million CNY | -19.94% |
| 2012 | 163.84 Million CNY | 1.87% |
| 2011 | 160.83 Million CNY | 14.76% |
| 2010 | 140.14 Million CNY | 16.16% |
| 2009 | 120.65 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 68.62 Million CNY | 8.96% |
| 2024 Q2 | 68.62 Million CNY | 0.0% |
| 2023 FY | 280.66 Million CNY | 1.09% |
| 2023 Q4 | 62.98 Million CNY | 0.0% |
| 2023 Q1 | 77.34 Million CNY | 7.47% |
| 2023 Q3 | 62.98 Million CNY | -18.56% |
| 2023 Q2 | 77.34 Million CNY | 0.0% |
| 2022 Q1 | 66.84 Million CNY | 2.82% |
| 2022 Q3 | 71.96 Million CNY | 7.66% |
| 2022 Q4 | 71.96 Million CNY | 0.0% |
| 2022 FY | 277.62 Million CNY | 5.32% |
| 2022 Q2 | 66.84 Million CNY | 0.0% |
| 2021 FY | 263.59 Million CNY | -5.91% |
| 2021 Q1 | 66.78 Million CNY | -21.53% |
| 2021 Q4 | 65.01 Million CNY | 0.0% |
| 2021 Q3 | 65.01 Million CNY | -2.65% |
| 2021 Q2 | 66.78 Million CNY | 0.0% |
| 2020 Q4 | 85.11 Million CNY | 0.0% |
| 2020 FY | 280.15 Million CNY | 4.77% |
| 2020 Q3 | 85.11 Million CNY | 54.86% |
| 2020 Q2 | 54.96 Million CNY | 0.0% |
| 2020 Q1 | 54.96 Million CNY | -9.85% |
| 2019 Q4 | 60.96 Million CNY | 0.0% |
| 2019 FY | 267.4 Million CNY | -14.16% |
| 2019 Q1 | 72.73 Million CNY | 6.01% |
| 2019 Q3 | 60.96 Million CNY | -16.17% |
| 2019 Q2 | 72.73 Million CNY | 0.0% |
| 2018 FY | 311.49 Million CNY | -3.61% |
| 2018 Q3 | 68.6 Million CNY | -21.27% |
| 2018 Q2 | 87.14 Million CNY | 0.0% |
| 2018 Q1 | 87.14 Million CNY | -0.16% |
| 2018 Q4 | 68.6 Million CNY | 0.0% |
| 2017 FY | 323.17 Million CNY | -0.12% |
| 2017 Q4 | 87.28 Million CNY | 0.0% |
| 2017 Q3 | 87.28 Million CNY | 17.48% |
| 2017 Q2 | 74.3 Million CNY | 0.0% |
| 2017 Q1 | 74.3 Million CNY | -20.54% |
| 2016 Q4 | 93.51 Million CNY | 0.0% |
| 2016 Q2 | 68.27 Million CNY | 0.0% |
| 2016 Q3 | 93.51 Million CNY | 36.96% |
| 2016 Q1 | 68.27 Million CNY | 22.63% |
| 2016 FY | 323.57 Million CNY | 42.68% |
| 2015 Q2 | 57.71 Million CNY | 0.0% |
| 2015 Q3 | 55.67 Million CNY | -3.53% |
| 2015 Q4 | 55.67 Million CNY | 0.0% |
| 2015 FY | 226.77 Million CNY | 45.08% |
| 2015 Q1 | 57.71 Million CNY | 47.95% |
| 2014 FY | 156.31 Million CNY | 19.16% |
| 2014 Q1 | 39.14 Million CNY | 13.2% |
| 2014 Q4 | 39 Million CNY | 0.0% |
| 2014 Q2 | 39.14 Million CNY | 0.0% |
| 2014 Q3 | 39 Million CNY | -0.35% |
| 2013 Q1 | 31 Million CNY | -20.81% |
| 2013 Q3 | 34.58 Million CNY | 11.52% |
| 2013 Q4 | 34.58 Million CNY | 0.0% |
| 2013 FY | 131.17 Million CNY | -19.94% |
| 2013 Q2 | 31 Million CNY | 0.0% |
| 2012 FY | 163.84 Million CNY | 1.87% |
| 2012 Q1 | 40.96 Million CNY | 0.0% |
| 2012 Q2 | 40.96 Million CNY | 0.0% |
| 2012 Q4 | 39.15 Million CNY | 0.0% |
| 2012 Q3 | 39.15 Million CNY | -4.4% |
| 2011 Q4 | 40.96 Million CNY | 1.87% |
| 2011 Q2 | 40.2 Million CNY | 0.0% |
| 2011 Q1 | 40.2 Million CNY | 0.0% |
| 2011 FY | 160.83 Million CNY | 14.76% |
| 2011 Q3 | 40.2 Million CNY | 0.0% |
| 2010 Q1 | 35.03 Million CNY | 0.0% |
| 2010 Q4 | 40.2 Million CNY | 14.76% |
| 2010 Q3 | 35.03 Million CNY | 0.0% |
| 2010 Q2 | 35.03 Million CNY | 0.0% |
| 2010 FY | 140.14 Million CNY | 16.16% |
| 2009 FY | 120.65 Million CNY | 0.0% |
| 2009 Q2 | 30.16 Million CNY | 0.0% |
| 2009 Q3 | 30.16 Million CNY | 0.0% |
| 2009 Q4 | 35.03 Million CNY | 16.16% |
| 2009 Q1 | 30.16 Million CNY | 0.0% |
| 2008 Q4 | 30.16 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| China Healthwise Holdings Limited | 60.29 Million HKD | -365.494% |
| Tycoon Group Holdings Limited | 301.24 Million HKD | 6.832% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 1.04 Billion HKD | 73.2% |